WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that the company’s Chief Scientific Officer, Robert Lanza, MD, has been recognized by BioWorld, a widely-read publication covering the biotechnology industry, as one of 28 leaders predicted to be the “movers and shakers” of the biotechnology industry over the next twenty years. The story is included in the publication’s 20th anniversary issue.
